Abstract | OBJECTIVE: DESIGN: Randomized controlled trial. SETTING: Large public tertiary hospital. PARTICIPANTS: Twenty-two T2D participants (11 men, 11 women; mean age +/- standard error, 56.2+/-1.1 y; diabetes duration, 8.8+/-3.5 y) were randomized into a 4-month ST program and 17 T2D participants (9 men, 8 women; mean age, 57.9+/-1.4 y; diabetes duration, 9.2+/-1.7 y) into a 4-month ET program. INTERVENTIONS: ST (up to 6 sets per muscle group per week) and ET (with an intensity of maximal oxygen consumption of 60% and a volume beginning at 15 min and advancing to a maximum of 30 min 3x/wk) for 4 months. MAIN OUTCOME MEASURES: RESULTS: A significant decline in Hb A1c was only observed in the ST group (8.3%+/-1.7% to 7.1%+/-0.2%, P=.001). Blood glucose (204+/-16 mg/dL to 147+/-8 mg/dL, P<.001) and insulin resistance (9.11+/-1.51 to 7.15+/-1.15, P=.04) improved significantly in the ST group, whereas no significant changes were observed in the ET group. Baseline levels of total cholesterol (207+/-8 mg/dL to 184+/-7 mg/dL, P<.001), low-density lipoprotein cholesterol (120+/-8 mg/dL to 106+/-8 mg/dL, P=.001), and triglyceride levels (229+/-25 mg/dL to 150+/-15 mg/dL, P=.001) were significantly reduced and high-density lipoprotein cholesterol (43+/-3 mg/dL to 48+/-2 mg/dL, P=.004) was significantly increased in the ST group; in contrast, no such changes were seen in the ET group. CONCLUSIONS: ST was more effective than ET in improving glycemic control. With the added advantage of an improved lipid profile, we conclude that ST may play an important role in the treatment of T2D.
|
Authors | Edmund Cauza, Ursula Hanusch-Enserer, Barbara Strasser, Bernhard Ludvik, Sylvia Metz-Schimmerl, Giovanni Pacini, Oswald Wagner, Petra Georg, Rudolf Prager, Karam Kostner, Attila Dunky, Paul Haber |
Journal | Archives of physical medicine and rehabilitation
(Arch Phys Med Rehabil)
Vol. 86
Issue 8
Pg. 1527-33
(Aug 2005)
ISSN: 0003-9993 [Print] United States |
PMID | 16084803
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- Glycated Hemoglobin A
- Lipids
|
Topics |
- Aged
- Analysis of Variance
- Blood Glucose
(analysis)
- Body Mass Index
- Diabetes Mellitus, Type 2
(physiopathology, rehabilitation)
- Exercise Therapy
(methods)
- Female
- Glycated Hemoglobin
(analysis)
- Humans
- Insulin Resistance
- Lipids
(blood)
- Male
- Middle Aged
- Muscle, Skeletal
(physiology)
- Physical Fitness
- Respiratory Function Tests
- Treatment Outcome
|